Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1395
TNBC
Basal B
CPT-11
TOP1
TOP
9254.121
uM
1.88410
7.72860
-0.6959 -0.9260 0.7425 0.3745
0.9815
1.2352
HCC1395
TNBC
Basal B
CPT-11
TOP1
TOP
9258.121
uM
0.8180
1.81820
-0.9944 -0.9150 1.3024 0.6132
0.9822
0.4800
HCC38
TNBC
Basal B
PD184352
MEK
MAPK
11850.155
uM
inf
inf
0.9060 0.9060 0.0000 0.0877
0.0000
2.1810
HCC38
TNBC
Basal B
PD173074
FGFR1/3
RTK
10578.1
uM
8.71610
17.04880
-0.9474 -1.0000 1.6375 0.3665
0.8880
1.6202
HCC1395
TNBC
Basal B
Dactolisib
PI3K
PI3K
12000.155
uM
inf
inf
0.6675 0.6675 0.0000 0.2919
0.2735
0.8592
HCC1395
TNBC
Basal B
Dactolisib
PI3K
PI3K
12084.155
uM
inf
inf
0.8548 0.8548 0.0000 0.1129
0.4499
1.2955
HCC38
TNBC
Basal B
PD 98059
MEK
MAPK
10578.136
uM
inf
25.79330
0.5933 0.5928 4.8756 0.0532
0.8707
1.5577
HCC1395
TNBC
Basal B
Dichloroacetate
PDK
PDK
13538.176
uM
inf
inf
0.8042 0.8042 0.0000 0.1436
0.3146
0.4572
HCC1395
TNBC
Basal B
Disulfiram
Proteasome
Proteasome
13538.174
uM
inf
0.14414
0.6866 0.6441 5.0000 0.1678
0.7406
0.4615
HCC38
TNBC
Basal B
PS-1145
IKK
NFKB
7469.065
uM
inf
61.95750
0.9161 0.9150 0.8933 0.0080
0.6490
2.0006
HCC38
TNBC
Basal B
PD173074
FGFR1/3
RTK
10418.093
uM
3.53430
7.85550
-0.9028 -1.0000 1.3755 0.2763
0.9686
0.9872
HCC1395
TNBC
Basal B
Docetaxel
TUBB
TUBB
7813.002
uM
0.00427
0.00565
-0.3992 -0.3837 2.0301 0.8129
0.9487
0.8463
HCC1395
TNBC
Basal B
Docetaxel
TUBB
TUBB
9254.002
uM
0.00740
0.00860
-0.5219 -0.5591 5.0000 0.8610
0.9829
0.3983
HCC38
TNBC
Basal B
PD173074
FGFR1/3
RTK
7468.093
uM
3.78550
10.17590
-0.7786 -1.0000 1.1110 0.2905
0.8947
1.4007
HCC1395
TNBC
Basal B
Docetaxel
TUBB
TUBB
9258.002
uM
0.00521
0.00815
-0.6370 -0.6272 1.8161 0.9088
0.9971
0.7065
HCC1395
TNBC
Basal B
Doxorubicin
TOP2
TOP
7816.007
uM
inf
inf
0.3187 0.3187 0.0000 0.2775
0.3760
1.1536
HCC38
TNBC
Basal B
PS-1145
IKK
NFKB
7468.065
uM
inf
inf
0.8447 0.8447 0.0000 0.0735
0.5698
1.5219
HCC38
TNBC
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7469.095
uM
inf
inf
0.9298 0.9298 0.0000 -0.0029
0.3387
1.8946
HCC1395
TNBC
Basal B
Doxorubicin
TOP2
TOP
9258.121
uM
0.06051
0.20762
-0.9952 -0.9809 0.8807 0.9474
0.9235
0.4800
HCC1395
TNBC
Basal B
Doxorubicin
TOP2
TOP
7813.007
uM
0.48027
1.07560
-0.9401 -0.8913 1.2692 0.6307
0.9841
0.8361
HCC38
TNBC
Basal B
PD184352
MEK
MAPK
11850.155
uM
inf
inf
0.9060 0.9060 0.0000 0.0877
0.0000
2.1810
HCC1395
TNBC
Basal B
Doxorubicin
TOP2
TOP
9254.121
uM
0.26202
0.84031
-0.7184 -0.7501 0.7863 0.6266
0.9951
1.2352
HCC1395
TNBC
Basal B
Epirubicin
TOP2
TOP
7816.017
uM
inf
inf
0.6386 0.6386 0.0000 0.2394
0.3980
1.2318
HCC38
TNBC
Basal B
PS-1145
IKK
NFKB
10418.065
uM
inf
inf
0.7550 0.7550 0.0000 0.0403
0.2487
0.9401
HCC38
TNBC
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
10418.095
uM
inf
inf
0.7496 0.7496 0.0000 0.1450
0.4999
1.1425